(HIVE) HIVE Blockchain - Ratings and Ratios

Exchange: V • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA43366H7040

HIVE: Bitcoin, Cryptocurrencies, Digital Currencies, Data Center Services

HIVE Digital Technologies Ltd. operates as a cryptocurrency mining and infrastructure company with operations in Canada, Sweden, and Iceland. The company specializes in the mining and sale of digital currencies, primarily Bitcoin, and provides computational resources to support blockchain networks. HIVE operates advanced data centers equipped with specialized hardware for cryptocurrency mining, leveraging low-cost, renewable energy sources in its host countries. The company also offers infrastructure solutions to support decentralized networks and blockchain applications. Formerly known as HIVE Blockchain Technologies Ltd., the company rebranded as HIVE Digital Technologies Ltd. in July 2023 to reflect its expanded focus on broader digital asset infrastructure. Incorporated in 1987 and headquartered in Vancouver, Canada, HIVE has established itself as a key player in the cryptocurrency mining and blockchain infrastructure space.

The companys strategic locations in Canada, Sweden, and Iceland provide access to cost-effective, sustainable energy, which is critical for cryptocurrency mining operations. HIVEs infrastructure supports not only Bitcoin mining but also other cryptocurrencies and decentralized applications, positioning the company as a diversified player in the blockchain ecosystem. With a market capitalization of 551.68M CAD, HIVE operates at the intersection of cryptocurrency mining and blockchain infrastructure, offering both mining services and computational power to support distributed networks.

Based on the technical data, HIVEs stock is currently trading at 2.96 CAD, below its 20-day, 50-day, and 200-day simple moving averages (3.85, 4.24, and 4.55, respectively). This indicates a bearish trend in the short to medium term. The average true range (ATR) of 0.28 suggests moderate volatility. Over the next three months, the stock is likely to face resistance at its 50-day SMA (4.24) and 200-day SMA (4.55). Support levels may emerge near the current price range, but the overall trend remains downward unless the price breaks above the 50-day SMA.

From a fundamental perspective, HIVEs forward P/E of 84.75 indicates high expectations for future earnings growth, though the current P/E is negative, reflecting losses in the most recent reporting period. The price-to-book (P/B) ratio of 0.97 suggests the stock is trading near its book value, indicating potential undervaluation. The price-to-sales (P/S) ratio of 4.56 is elevated, signaling that investors are paying a premium for revenue growth. With a return on equity (RoE) of -1.52, the company is currently unprofitable on an equity basis. Over the next three months, HIVEs ability to improve operational efficiency and reduce losses will be critical to reversing the negative sentiment.

Additional Sources for HIVE Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

HIVE Stock Overview

Market Cap in USD 251m
Sector Financial Services
Industry Capital Markets
GiC Sub-Industry Investment Banking & Brokerage
IPO / Inception

HIVE Stock Ratings

Growth 5y -55.6%
Fundamental -43.2%
Dividend 0.0%
Rel. Strength -58.2
Analysts -
Fair Price Momentum 1.47 CAD
Fair Price DCF -

HIVE Dividends

No Dividends Paid

HIVE Growth Ratios

Growth Correlation 3m -96.4%
Growth Correlation 12m -1.6%
Growth Correlation 5y -70.9%
CAGR 5y -19.20%
CAGR/Max DD 5y -0.19
Sharpe Ratio 12m -1.46
Alpha -32.93
Beta 4.589
Volatility 87.43%
Current Volume 753.9k
Average Volume 20d 760k
What is the price of HIVE stocks?
As of April 07, 2025, the stock is trading at CAD 1.98 with a total of 753,867 shares traded.
Over the past week, the price has changed by -7.91%, over one month by -28.00%, over three months by -59.18% and over the past year by -54.48%.
Is HIVE Blockchain a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, HIVE Blockchain (V:HIVE) is currently (April 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -43.20 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HIVE as of April 2025 is 1.47. This means that HIVE is currently overvalued and has a potential downside of -25.76%.
Is HIVE a buy, sell or hold?
HIVE Blockchain has no consensus analysts rating.
What are the forecast for HIVE stock price target?
According to ValueRays Forecast Model, HIVE HIVE Blockchain will be worth about 1.8 in April 2026. The stock is currently trading at 1.98. This means that the stock has a potential downside of -11.11%.
Issuer Forecast Upside
Wallstreet Target Price 7 253.5%
Analysts Target Price - -
ValueRay Target Price 1.8 -11.1%